Effects of food on E7050 pharmacokinetics, and pharmacokinetics after single oral doses of 100-400mg in healthy subjects.
Latest Information Update: 16 Jan 2020
At a glance
- Drugs Golvatinib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors Eisai Co Ltd
- 28 Aug 2015 New source integrated ClinicalTrials.gov (NCT02533102).
- 26 Jan 2012 Status changed from not stated to completed.
- 20 Dec 2011 New trial record